In comparison with the control group, the relative protein expression levels of TP53 were increased after treatment with the CLYF formula in HepG2 cells (Figure 14A,C), indicating that the Naxi traditional formula CLYF may possess anti-cancer activity. Here, TP53 is linked to cancer.